Search

Showing "11155" results for ""

TB transmission in healthcare settings and improving infection control

TB-related immune reaction to HIV therapy occurs 20 months after TB treatment first started - is this a record?

A simpler, cheaper way to assess HIV-positive children’s health

Emergence of resistance mutations: a comparison between drug classes

Bevirimat, first maturation inhibitor: tablet formulation provides lower than expected plasma levels

Gut microbes linked to immune activation, HIV disease progress, may explain long-term CD4 loss

After 48 weeks of study, and 24 weeks in the real world, darunavir continues to show staying power

Urban myth deters men in London from seeking sexual health screens

Orphans in Kenya respond well to antiretroviral therapy

No link between drug use and unprotected sex amongst HIV-positive gay men in Sydney

Women who take NNRTI have more cervical HIV shedding than those who take a PI

Uneven PEP awareness amongst people living with HIV in France

Living with HIV in France in the 21st century: Employment, response to treatment, and quality of life

Methamphetamine use causes stroke

Approximately a third of people with HIV plan to have children

Previous poor adherence and HCV are risk factors for antiretroviral treatment failure

New treatment for facial fat loss approved in US

People with AIDS have increased lung cancer risk, and it's not all due to smoking

Receive the latest HIV research and conference news

Showing "11155" results for ""

TB transmission in healthcare settings and improving infection control

TB-related immune reaction to HIV therapy occurs 20 months after TB treatment first started - is this a record?

A simpler, cheaper way to assess HIV-positive children’s health

Emergence of resistance mutations: a comparison between drug classes

Bevirimat, first maturation inhibitor: tablet formulation provides lower than expected plasma levels

Gut microbes linked to immune activation, HIV disease progress, may explain long-term CD4 loss

After 48 weeks of study, and 24 weeks in the real world, darunavir continues to show staying power

Urban myth deters men in London from seeking sexual health screens

Orphans in Kenya respond well to antiretroviral therapy

No link between drug use and unprotected sex amongst HIV-positive gay men in Sydney

Women who take NNRTI have more cervical HIV shedding than those who take a PI

Uneven PEP awareness amongst people living with HIV in France

Living with HIV in France in the 21st century: Employment, response to treatment, and quality of life

Methamphetamine use causes stroke

Approximately a third of people with HIV plan to have children

Previous poor adherence and HCV are risk factors for antiretroviral treatment failure

New treatment for facial fat loss approved in US

People with AIDS have increased lung cancer risk, and it's not all due to smoking

Receive the latest HIV research and conference news